L’Etat français, seul payeur et régulateur, joue un rôle inédit sur le marché de la santé en cadrant les dépenses de santé, l’offre de soin publique et l’accès des industriels aux professionnels de santé et aux patients sans toutefois avoir la main sur les traitements qui restent l’apanage des laboratoires pharmaceutiques…
Only logged in customers who have purchased this product may leave a review.
You may also like
In 2007, medical leaders from across the pharmaceutical industry assembled to develop a common understanding of a ten-year vision for Medical Affairs. With five years now past, it is hardly surprising that significant change has occurred in the world in which the pharmaceutical industry operates, especially given the remarkable economic environment and the continued acceleration of technological change.
Pharma Medical Affairs 2020 and beyond$0.00 McKinsey
This paper complements PwC’s Project Blue1 and the PwC Megatrends framework2, which examines the forces that are disrupting the role, structure, and competitive environment for financial institutions and the markets and societies in which they operate.
Financial Services Technology 2020 and Beyond$0.00 Pwc
As the game industry continues to grow and expand its target market to nearly every person with access to an Internet connection, the capabilities needed to gain a competitive advantage are changing too.
The Pulse of Gaming$0.00 Accenture
Trouble with Conavigo
Want to refine your results?
Help with Sourcing
Need help with your Sourcing?